Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news: 1 news outlet
twitter: 11 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 111 Dimensions

Readers on

mendeley: 89 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 12 X posts from 11 X users, with an upper bound of 55,313 followers.

RT @alexshoushtari: There are now 2 retrospective reports of nivo+ipi in UM; one US-based (@YanaNajjarMD @FunchainMD, others) and one Europ…

17 Aug 2020

Reply Repost Favourite

There are now 2 retrospective reports of nivo+ipi in UM; one US-based (@YanaNajjarMD @FunchainMD, others) and one Europe-based . ORR in both is low, 12-16% (vs skin ORR 55-60%). Toxicity looked just as high, unfortunately. https://t.co/Y2oQMdYI44 https://

29 Jun 2020

Reply Repost Favourite

RT @jitcancer: #JITC Research: Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study https…

06 Dec 2019

Reply Repost Favourite

#JITC Research: Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study https://t.co/s2XNJHNEdc https://t.co/bghAoimjQT

06 Dec 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.